Lataa...
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
BACKGROUND: Hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling attacks. A European treatment registry was established to review the adverse event profile and efficacy of recombinant human C1 esterase inhibitor (rhC1-INH) for HAE at...
Tallennettuna:
| Julkaisussa: | World Allergy Organ J |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
World Allergy Organization
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093463/ https://ncbi.nlm.nih.gov/pubmed/33995818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2021.100535 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|